Lucas Moreno

Also affiliated with Vall d'Hebron Hospital Universitari

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Opportunities and Challenges in Drug Development for Pediatric Cancers”.

Opportunities and Challenges in Drug Development for Pediatric Cancers

Cancer Discovery(2020)10.1158/2159-8290.cd-20-0779

N/A

0DataRank · unranked

73 citations

Steven G. DuBois, Julia Glade Bender, Margaret E. Macy, Lucas Moreno, Theodore W. Laetsch

Early‐phase clinical trial eligibility and response evaluation criteria for refractory, relapsed, or progressive neuroblastoma: A consensus statement from the National Cancer Institute Clinical Trials Planning Meeting

Cancer(2022)10.1002/cncr.34445

N/A

0DataRank · unranked

14 citations

Judith G. Villablanca, Barbara Hero, Brian H. Kushner, Keith Wheatley, Klaus Beiske +9 more

Induction Regimens in High‐Risk Neuroblastoma: Systematic Review of Response Rates and Toxicities

Cancer Medicine(2025)10.1002/cam4.71312

N/A

0DataRank · unranked

0 citations

Eva C. Robinson, Edie Weller, Rochelle Bagatell, Lucas Moreno, Steven G. DuBois +1 more